Trascript of Earnings Call Q1 FY 2026-27

AI summary - Q1 FY27 revenue INR534 Cr +51% y-y; EBITDA INR131 Cr +65% y-y; PAT INR85 Cr +95% y-y - Gross margin improved sequentially by 140 bps to 67.7% despite input cost rise - EBITDA margin guided upwards to 23% for FY27 from earlier 22-23% - Arinna acquisition contributed INR12 Cr revenue; EBITDA impact immaterial - US manufacturing facility acquisition strategic; commercial operations to start CY27 - R&D spend at 10.9% of revenue; productivity at 5.5x; INR500 Cr spend guidance on track - Management change: CFO Nitin Jajodia to Chief Commercial Officer; Rohit appointed CFO designate - Specialty portfolio contributes 36% to gross profit; broad-based product growth continues - Pithampur facility FDA approved; ramp-up expected from Q1 CY27; significant expansion headroom - Multiple analyst queries on product pipeline and AI adoption; management cautious on AI specifics